Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Patient Perceived Stress
NCT06778421Phase 1Completed
- Sponsor
- Center for Advanced Facial Plastic Surgery
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in stress (2 arms), sponsored by Center for Advanced Facial Plastic Surgery. Primary endpoint: Perceived Stress Scale. Started Mar 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
stress
Beyond the preview
Go deeper on NCT06778421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778421.